Loading
A phase 1/2 trial of bevacizumab, oxaliplatin and capecitabine in colorectal cancer, run by Nanjing Leads Biolabs Co.,Ltd, not yet recruiting.
A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma is a phase 1/2, randomised interventional study registered as NCT07791758 by Nanjing Leads Biolabs Co.,Ltd, with a registry enrolment figure of 369 participants, started 2026-09-04 and due to reach its primary completion in 2030-09-04. Interventions recorded: LBL-024 for Injection; Bevacizumab injection; Oxaliplatin injection; Capecitabine tablets; Fruquintinib Capsules. Conditions listed: Metastatic Colorectal Carcinoma. Primary outcome: Objective Response Rate (ORR); Occurrence of adverse event (AE) and serious adverse event (SAE). Sites: China. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Bevacizumab, Anti-angiogenic therapy, Capecitabine, Monoclonal antibodies and the tag colorectal-deep-dive.
Shares Capecitabine, Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Capecitabine, Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Capecitabine, Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Capecitabine, Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Capecitabine, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Capecitabine, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Bevacizumab, Anti-angiogenic therapy, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/